GreatBay Bio to Showcase AI-Driven Biologics Platforms at BIO International Convention 2026

The BIO International Convention 2026, the world's premier biotechnology event, will officially commence from June 22 to 25 at the San Diego Convention Center in the United States.The conference brings together 20,000 industry professionals from around the world, focusing on cutting-edge sectors such as biopharmaceuticals, cell and gene therapy, AI-driven drug discovery, and biomanufacturing, serving as a core platform for international technological exchange and business collaboration.

▲BIO International Convention 2026

GBB will showcase its core technologies (Booth No.: 2211, Hong Kong Pavilion). Global industry professionals are welcome to visit and discuss collaboration.

▲ GBB Booth No.: 2211

At the event, we will share in-depth practical experience on how multiple intelligent technology platforms facilitate the process scale-up and commercialization of clients' R&D projects:

● Intelligent Molecular Design Platform (AlfaBodY): Adopts a closed-loop dry-wet experimental iteration model, enabling rapid delivery of a PCC within 8 months, with exceptional adaptability to difficult-to-drug targets;

● AI-Driven Molecular Assessment and Optimization Platform (AlfaDAX): AI powers an end-to-end solution encompassing “sequence input – intelligent assessment – precise optimization,” rapidly predicting key developability metrics such as isoelectric point, humanness score, immunogenicity, stability, and aggregation/precipitation risk. It disruptively enables simultaneous three-dimensional optimization of molecular affinity, humanization, and developability, empowering clients to shorten R&D cycles, mitigate risks, and generate clinical-grade candidate molecules.

● Intelligent Site-Specific Integration Cell Line Development Platform (AlfaCell): Precisely inserts target genes into stable, high-expression, and high-quality highly active genomic loci, enabling the rapid generation of high-yield stable cell lines within 1.5 months, demonstrating significant efficacy in overcoming challenges in complex molecule development;

● Intelligent Cell Culture Media Development Platform (AlfaMedX): An algorithm-driven media formulation platform specifically optimized for CHO-K1 cell lines, delivering superior protein expression levels compared to mainstream commercial media across most application scenarios.

We cordially invite partners from all sectors to visit our booth for exchanges and discussions, and jointly explore new avenues for collaboration!

Founded in 1993, the BIO International Convention is the world's largest biotechnology industry gathering. It brings together leading biopharmaceutical companies, investors, and partners from around the globe, with numerous partnering events held throughout the conference to provide a promotional and exhibition platform for enterprises, science and technology parks, and R&D institutions worldwide. The convention is organized by the Biotechnology Innovation Organization (BIO), the world's largest trade association representing biotechnology companies, academic institutions, and related organizations.

Themed “Driven by Purpose,” this conference focuses on the social value and patient benefits of biotechnology innovation, driving the translation of scientific breakthroughs into real-world impact.

▲BIO International Convention 2026 Sponsors